FDA Inspection 861075 — Octapharma Plasma, Inc.
The FDA completed an inspection of Octapharma Plasma, Inc. on Dec 9, 2013 in Evansville, IN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 9, 2013
- Fiscal Year
- 2014
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Evansville, IN (United States)